Aminoisoquinoline thrombin inhibitor with improved bioavailability
US8299091B2 · kind B2 · utility
0Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2007 |
| Grant date | Oct 30, 2012 |
| Priority date | — |
| Expiry date | Jul 14, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/0202
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the compound N-(2-oxo-2-propoxyethyl)-β-phenyl-D-phenyl-alanyl-N-[(1-amino-6-iso-quinolinyl)methyl]-L-prolinamide or a pharmaceutically acceptable salt thereof, to a pharmaceutical composition comprising said compound, as well as to the use of the compound for the manufacture of a medicament for treating or for preventing thrombin mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.